Valve-in-valve transcatheter aortic valve implantation overcoming hostile anatomy: Evolut R for the treatment of Mitroflow bioprosthesis dysfunction

Neil Ruparelia, Antonio Colombo, Azeem Latib

Research output: Contribution to journalArticlepeer-review

Abstract

Redo surgery is regarded as the first-line treatment option for patients presenting with prosthetic valve degeneration. However, many patients have concomitant co-morbidities and this option is associated with significant risk. Transcatheter valve-in-valve implantation is an alternative strategy depending on the bioprosthetic valve that is being treated. The Sorin Mitroflow bioprosthetic aortic valve has been regarded as a contraindication to valve-in-valve treatment due to the high risk of coronary obstruction. We here present the case of a patient with small peripheral vasculature who underwent successful transfemoral valve-in-valve implantation and subsequently discuss the challenges and technical aspects that require consideration.

Original languageEnglish
Pages (from-to)292-295
Number of pages4
JournalCardiovascular Intervention and Therapeutics
Volume31
Issue number4
DOIs
Publication statusPublished - Oct 1 2016

Keywords

  • Coronary obstruction
  • Evolut R
  • Mitroflow
  • Transcatheter aortic valve implantation
  • Valve-in-valve

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Valve-in-valve transcatheter aortic valve implantation overcoming hostile anatomy: Evolut R for the treatment of Mitroflow bioprosthesis dysfunction'. Together they form a unique fingerprint.

Cite this